Global Biologic Therapeutics Industry 2015 - 2019 Market Size and Share, Growth, Market Price, Analysis, Forecast and Overview

Hexa Reports
Market Research Reports and Insightful Company Profiles

Global Biologic Therapeutics Industry 2015 - 2019
Market Size and Share, Growth, Market Price,
Analysis, Forecast and Overview

Biologic therapeutics include virus, therapeutic serums, toxins, allergenic products, antitoxin, blood
components or derivatives, vaccines, blood, and proteins (except any chemically synthesized
polypeptide). They also include analogous products, arsphenamine, or derivatives of arsphenamine (or
any other trivalent organic arsenic compound) for the prevention, treatment, or cure of a disease. The
differences between the biologics and small molecules include the molecular weight, structure,
procedure of synthesis, and immunogenicity. Biologics have a higher molecular weight and a complex
molecular structure. They are usually derived from living entities, which is another important feature
that differentiates it from small molecules. Biologics are also vulnerable to extreme temperatures
(thermolabile) and light.
Browse Detail Report With TOC @ http://www.hexareports.com/report/global-biologic-therapeuticsmarket/details
Covered in this report
This report covers the present scenario and the growth prospects of the global biologic therapeutics
market for the period 2015-2019. To calculate the market size, the report considers revenue generated
through the sales protein therapeutics (monoclonal antibodies, enzymes, and other protein
therapeutics).
Other protein therapeutics covers proteins such as cytokines, fusion proteins, peptide antibiotics,
peptide hormones, and blood factors.
The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors
in the market. The vendor landscape section includes a market share analysis of the major vendors along
with the competitive performances of their product portfolios.

Hexa Reports
Market Research Reports and Insightful Company Profiles
Table Of Content
PART 01:...